Thomas John
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Occupational and environmental lung diseases
- Oncology top 1%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 74
- Occupational and environmental lung diseases 24
- Lung Cancer Diagnosis and Treatment 14
- Oncology 89
- Cancer Immunotherapy and Biomarkers 37
- Lung Cancer Research Studies 28
- Colorectal Cancer Treatments and Studies 21
- Co-authors
- Frances A. Shepherd (19 shared papers)Alexander Dobrovic (12 shared papers)Puey Ling Chia (14 shared papers)Ming‐Sound Tsao (10 shared papers)Geoffrey Liu (4 shared papers)Paul Mitchell (16 shared papers)Suresh S. Ramalingam (9 shared papers)Yi‐Long Wu (19 shared papers)
- Journals
- Journal of Thoracic Oncology (27 papers)Annals of Oncology (24 papers)Journal of Clinical Oncology (14 papers)Lung Cancer (12 papers)Translational Lung Cancer Research (7 papers)
- Partner nations
- AustraliaUnited StatesJapan
In The Last Decade
Thomas John
211 papers receiving 5.6k citations
Thomas John's Hit Papers
Peers
Comparison fields: 5 of 125
- Pulmonary and Respiratory Medicine 3.0k
- Oncology 2.3k
- Cancer Research 778
- Ophthalmology 260
- Immunology 433
Countries citing papers authored by Thomas John
This map shows the geographic impact of Thomas John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas John more than expected).
Fields of papers citing papers by Thomas John
This network shows the impact of papers produced by Thomas John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas John. The network helps show where Thomas John may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas John, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 225 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Osimertinib As First-Line Treatment of EGFR Mutation–Positive Advanced Non–Small-Cell Lung Cancer Hit paper breakdown → | 2017 | 386 |
| 2 | Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC Hit paper breakdown → | 2023 | 300 |
| 3 | 2020 | 192 | |
| 4 | 2018 | 178 | |
| 5 | 2009 | 176 | |
| 6 | 2009 | 169 | |
| 7 | 2014 | 148 | |
| 8 | 2019 | 146 | |
| 9 | 2017 | 139 | |
| 10 | 2010 | 132 | |
| 11 | 2020 | 120 | |
| 12 | 1997 | 107 | |
| 13 | 2020 | 106 | |
| 14 | Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial Hit paper breakdown → | 2023 | 106 |
| 15 | 2002 | 105 | |
| 16 | 2013 | 101 | |
| 17 | 2017 | 89 | |
| 18 | 2017 | 83 | |
| 19 | 2008 | 77 | |
| 20 | 2017 | 76 |
About Thomas John
Thomas John is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Immunology, having authored 225 papers that have together received 5.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (74 papers), Cancer Immunotherapy and Biomarkers (37 papers), Cancer Genomics and Diagnostics (28 papers), Lung Cancer Research Studies (28 papers), Occupational and environmental lung diseases (24 papers), Colorectal Cancer Treatments and Studies (21 papers), Immunotherapy and Immune Responses (14 papers) and Lung Cancer Diagnosis and Treatment (14 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.0k citations), Oncology (2.3k citations), Cancer Research (778 citations), Ophthalmology (260 citations) and Immunology (433 citations). Thomas John has collaborated with scholars based in Australia, United States and Japan. Frequent co-authors include Frances A. Shepherd, Alexander Dobrovic, Puey Ling Chia, Ming‐Sound Tsao, Geoffrey Liu, Paul Mitchell, Suresh S. Ramalingam, Yi‐Long Wu, Yuri Rukazenkov and James Chih‐Hsin Yang. Their work appears in journals such as Journal of Thoracic Oncology, Annals of Oncology, Journal of Clinical Oncology, Lung Cancer and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.